002007 华兰生物
已收盘 04-30 15:00:00
资讯
新帖
简况
中邮证券:给予华兰生物买入评级
证券之星 · 04-26
中邮证券:给予华兰生物买入评级
圣诺医药-B(02257.HK)旗下达冕生物与华兰生物疫苗达成战略合作
阿斯达克财经 · 04-26
圣诺医药-B(02257.HK)旗下达冕生物与华兰生物疫苗达成战略合作
华兰生物(002007.SZ)发一季度业绩,净利润2.62亿元,同比减少25.56%
智通财经 · 04-25
华兰生物(002007.SZ)发一季度业绩,净利润2.62亿元,同比减少25.56%
华兰生物最新公告:一季度净利润同比下降25.56%
证券之星 · 04-25
华兰生物最新公告:一季度净利润同比下降25.56%
华兰生物双轮驱动营收突破53亿创新高 疫苗制品毛利率88.32%四年分红超20亿
市场资讯 · 04-11
华兰生物双轮驱动营收突破53亿创新高 疫苗制品毛利率88.32%四年分红超20亿
华兰生物业绩阴沉两年后放晴 去年归母净利同比增长37.66%
每日经济新闻 · 04-01
华兰生物业绩阴沉两年后放晴 去年归母净利同比增长37.66%
加载更多
公司概况
公司名称:
华兰生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2004-06-25
主营业务:
华兰生物工程股份有限公司是一家主要从事血液制品、菌疫苗的生产和销售的公司.公司的主要产品包括人血白蛋白、静注人免疫球蛋白(PH4)、人凝血酶原复合物、人凝血因子Ⅷ等.公司目前生产规模、市场占有率均居行业前列,成为血液制品、疫苗产品行业的龙头企业。凭借30多年来安全、稳定、高效的产品赢得了广大用户的信任,现已发展成为国内品牌影响力最强、最具竞争力的大型生物医药企业之一。在国内血液制品、疫苗行业起到引导市场、带动产业发展和科技创新的龙头作用,“华兰”商标被认定为中国驰名商标,公司荣膺“国家高技术产业化示范工程企业”、“河南省先进高新技术企业”、“河南省高新技术产业化项目实施先进单位”等称号。
发行价格:
15.74
{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":19.47,"timestamp":1714460628000,"preClose":19.46,"halted":0,"volume":10060119,"delay":0,"floatShares":1574000000,"shares":1829000000,"eps":0.761,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"04-30 15:00:00","open":19.41,"high":19.61,"low":19.36,"amount":196000000,"amplitude":0.0128,"askPrice":19.48,"askSize":6,"bidPrice":19.47,"bidSize":77,"shortable":0,"etf":0,"ttmEps":0.761,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":19.46,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":21.41,"lowLimit":17.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1828780926,"pbRate":3.06,"roa":"--","roe":"2.28%","epsLYR":0.8121,"committee":-0.691321,"marketValue":35606000000,"floatMarketCap":30638000000,"peRate":25.584758,"changeRate":0.0005,"turnoverRate":0.0064,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-05-06。"},"requestUrl":"/m/hq/s/002007","defaultTab":"news","newsList":[{"id":"2430267202","title":"中邮证券:给予华兰生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430267202","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430267202?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:02","pubTimestamp":1714125735,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,陈成近期对华兰生物进行研究并发布了研究报告《高基数下Q1增速放缓,看好全年采浆端快速增长》,本报告对华兰生物给出买入评级,当前股价为18.54元。维持推荐,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有16家机构给出评级,买入评级14家,增持评级2家;过去90天内机构目标均价为24.76。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600044110.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430211940","title":"圣诺医药-B(02257.HK)旗下达冕生物与华兰生物疫苗达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2430211940","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430211940?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:48","pubTimestamp":1714110480,"startTime":"0","endTime":"0","summary":"圣诺医药-B(02257.HK) 宣布,旗下非控股子公司达冕生物,与华兰生物疫苗股份有限公司达成战略合作。相关合作将推动针对呼吸道合胞病毒(RSV)的mRNA疫苗RV-1770,于中国的临床开发及商业化。(js/a)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-26 12:25。)AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220513155535487_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220513155535487_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345397/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430401989","title":"华兰生物(002007.SZ)发一季度业绩,净利润2.62亿元,同比减少25.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430401989","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430401989?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:52","pubTimestamp":1714045956,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华兰生物(002007.SZ)发布2024年第一季度报告,营业收入7.87亿元,同比减少10.60%。归属于上市公司股东的净利润2.62亿元,同比减少25.56%。归属于上市公司股东的扣除非经常性损益的净利润2.21亿元,同比减少19.66%。基本每股收益0.1431元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110382.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430405764","title":"华兰生物最新公告:一季度净利润同比下降25.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430405764","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430405764?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:20","pubTimestamp":1714044036,"startTime":"0","endTime":"0","summary":"华兰生物发布2024年第一季度报告,实现营业收入7.87亿元,同比下降10.6%;归属于上市公司股东的净利润2.62亿元,同比下降25.56%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500040313.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426476411","title":"华兰生物双轮驱动营收突破53亿创新高 疫苗制品毛利率88.32%四年分红超20亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2426476411","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426476411?lang=zh_cn&edition=full","pubTime":"2024-04-11 08:45","pubTimestamp":1712796300,"startTime":"0","endTime":"0","summary":" 近日,华兰生物公布2023年年报,公司实现营业收入53.42亿元,同比增长18.26%,创公司历史新高;归母净利润14.82亿元,同比增长37.66%,仅次于2020年的16.13亿元;扣非净利润12.67亿元,同比增长41.77%。数据显示,华兰生物核心业务血液制品实现营收29.26亿元,同比增长9.22%,毛利率54.34%;疫苗制品实现营收24.05亿元,同比增长32.3%,毛利率88.32%。对此,华兰生物的解释是“主要系民众接种疫苗意愿上升所致”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-11/doc-inarmiaa0350829.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-11/doc-inarmiaa0350829.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424670933","title":"华兰生物业绩阴沉两年后放晴 去年归母净利同比增长37.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424670933","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2424670933?lang=zh_cn&edition=full","pubTime":"2024-04-01 22:27","pubTimestamp":1711981620,"startTime":"0","endTime":"0","summary":" 随着疫情影响消退,华兰生物阴沉了两年的业绩终于放晴。 3月29日,华兰生物发布2023年年报,公司实现营业收入53.42亿元,同比增长18.26%;实现归母净利润14.82亿元,同比增长37.66%;经营活动产生的现金流量净额为13.46亿元,同比增长40.59%。 数据显示,2023年华兰生物的疫苗制品生产量为2535.73万支,同比减少5.60%,销售量为1939.75万支,同比增长33.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-04-01/doc-inaqizvn7893680.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-04-01/doc-inaqizvn7893680.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","stockEarnings":[{"period":"1week","weight":0.0204},{"period":"1month","weight":-0.0347},{"period":"3month","weight":0.1062},{"period":"6month","weight":-0.169},{"period":"1year","weight":-0.1522},{"period":"ytd","weight":-0.1202}],"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","perCapita":"35000股","boardName":"医药制造业","registeredCapital":"182878万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 华兰生物工程股份有限公司是一家主要从事血液制品、菌疫苗的生产和销售的公司.公司的主要产品包括人血白蛋白、静注人免疫球蛋白(PH4)、人凝血酶原复合物、人凝血因子Ⅷ等.公司目前生产规模、市场占有率均居行业前列,成为血液制品、疫苗产品行业的龙头企业。凭借30多年来安全、稳定、高效的产品赢得了广大用户的信任,现已发展成为国内品牌影响力最强、最具竞争力的大型生物医药企业之一。在国内血液制品、疫苗行业起到引导市场、带动产业发展和科技创新的龙头作用,“华兰”商标被认定为中国驰名商标,公司荣膺“国家高技术产业化示范工程企业”、“河南省先进高新技术企业”、“河南省高新技术产业化项目实施先进单位”等称号。","serverTime":1714914884957,"listedPrice":15.74,"stockholders":"158000人(较上一季度减少5.49%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}